Sandrine Pirard

Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Drug and Alcohol Dependence November 1, 2014 Marisol S. Castaneto, David A. Gorelick, Nathalie A. Desrosiers et al.

Synthetic cannabinoids (SC) are a heterogeneous group of compounds developed to probe the endogenous cannabinoid system or as potential therapeutics. Clandestine laboratories subsequently utilized published data to develop SC variations marketed as abusable designer drugs. In the early 2000s, SC became popular as "legal highs" under brand names such as Spice and K2, in part due to their ability...